ArticlePharmaceuticals (Basel, Switzerland)2023

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches.

Aisha A Alsfouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.